As many as 1 in 5 people won't lose weight with GLP-1 drugs, experts say
About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to ...
What costs $1,349 in the US is only $92 in the UK. Why are weight loss drugs so pricey?
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
pulmonologyadvisor2h
GLP-1RA Dispensing Trends Indicate Shifting Landscape in Obesity Treatment
GLP-1RA dispensing has increased from 2022 and 2023, whereas metabolic bariatric surgery has decreased among individuals with obesity.
Health and Me on MSN2h
When Ozempic And Wegovy Fail To Work- Why GLP-1 Drugs Aren’t The Magic Bullet For Everyone
When Ozempic and Wegovy don’t work, genetic differences, medical conditions, or side effects could be to blame. Is it normal, ...
Medscape4h
Diabetes Drugs Promising for Alcohol Use Disorder
Compared with standard AUD medications, the use of semaglutide and liraglutide was linked to a lower risk for alcohol use ...
News Medical1d
GLP-1 receptor agonists prove effective for kidney and cardiovascular outcomes
The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and ...
CMAJ1d
Glucagon-like peptide-1 receptor agonists for treating chronic kidney disease in patients with type 2 diabetes
In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) between 25 and 75 mL/min/1.73 m2, subcutaneous semaglutide reduced the ...
Medscape4h
GLP-1 RA Drug Class Benefits People With SLE, Lupus Nephritis
The glucose-lowering and weight-reducing drug class appears to benefit the heart and kidneys in people with lupus and lupus nephritis, independently of glucose-lowering and weight loss.
Lexaria Bioscience completes dosing for GLP-1 human pilot study #3
Lexaria Bioscience (LEXX) announced that dosing has been completed for human pilot study #3 investigating a DehydraTECH-processed version of ...
News Medical on MSN6d
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption
The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
Eli Lilly reported total tirzepatide sales that rocketed 272% year over year to $11 billion during the first nine months of ...
What Are Compounded GLP-1 Medications for Weight Loss?
GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...